: Form I can be quantitatively converted into Form II.
Acitretin is a second-generation retinoid and a metabolite of etretinate. While effective for severe psoriasis, its physical properties are highly dependent on the crystallization process. Because different crystalline structures (polymorphs) can change the drug’s solubility and shelf-life, precise characterization is essential for regulatory compliance and patient safety ( ResearchGate ). 2. Characterization of Polymorphic Forms
Acitretin (54757-46-9) is an oral retinoid utilized for treating severe dermatological conditions. Recent structural studies have identified at least three distinct polymorphic phases (Forms I, II, and III). Understanding these polymorphs is critical for pharmaceutical stability and bioavailability. This paper summarizes the structural differences between these forms and the thermal conditions required for phase transition. 1. Introduction 54757.rar
Researchers using X-ray powder diffraction (XRPD) and thermal analysis have identified three primary forms:
AI responses may include mistakes. For financial advice, consult a professional. Learn more : Form I can be quantitatively converted into Form II
The ability to characterize these moderately complex substances from powder diffraction data allows for a better understanding of their crystal chemistry. For Acitretin (54757-46-9), the transition between dimers and catamers represents a significant shift in molecular arrangement that must be monitored during the production of oral retinoid therapies.
: Also features carboxylic dimers but is located on crystallographic inversion centers. Recent structural studies have identified at least three
: The standard material deposited in the European Pharmacopoeia. It consists of four crystallographically independent molecules arranged in pairs via hydrogen-bonded carboxylic dimers ( ResearchGate ).